Elanco Animal Health Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $4.7B | $4.4B | $4.4B | $4.4B | $4.8B |
| Gross profit | $2.6B | $2.4B | $2.5B | — | — |
| Cost of revenue | $2.1B | $2.0B | $1.9B | $1.9B | $2.1B |
| Cash from operations | $560.0M | $541.0M | $271.0M | $452.0M | $483.0M |
| Capital expenditure | $276.0M | $147.0M | $140.0M | $171.0M | $159.0M |
| Free cash flow | $284.0M | $394.0M | $131.0M | $281.0M | $324.0M |
| Impairments | $71.0M | $81.0M | $32.0M | $0 | $66.0M |
| Total assets | $13.4B | $12.6B | $14.4B | $15.5B | $16.5B |
| Total liabilities | $6.8B | $6.5B | $8.1B | $8.2B | $9.0B |
| Total debt | $3.8B | $4.3B | $5.8B | $5.9B | $6.4B |
Shares outstanding 499.4M · Free float 17.4%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.